1-6 of 6
Terri S. Armstrong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases

Available to Purchase
Sarah Jenkins, Wei Zhang, Seth M. Steinberg, Darryl Nousome, Nicole Houston, Xiaolin Wu, Terri S. Armstrong, Eric Burton, Dee Dee Smart, Ritu Shah, Cody J. Peer, Brett Mozarsky, Oluwatobi Arisa, William D. Figg, Tito R. Mendoza, Elizabeth Vera, Priscilla Brastianos, Scott Carter, Mark R. Gilbert, Carey K. Anders, Roisín M. Connolly, Carol Tweed, Karen L. Smith, Imran Khan, Stanley Lipkowitz, Patricia S. Steeg, Alexandra S. Zimmer
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (8): 1450–1459.
https://doi.org/10.1158/1078-0432.CCR-22-0855
Published: 14 April 2023
View articletitled, Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
Open the PDF for Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases in another window
Includes: Supplementary data
Journal Articles

Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2

Available to Purchase
Yang Liu, Fu-Ju Chou, Fengchao Lang, Meili Zhang, Hua Song, Wei Zhang, Dionne L. Davis, Nicole J. Briceno, Yang Zhang, Patrick J. Cimino, Kareem A. Zaghloul, Mark R. Gilbert, Terri S. Armstrong, Chunzhang Yang
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (7): 1305–1316.
https://doi.org/10.1158/1078-0432.CCR-22-3179
Published: 03 April 2023
View articletitled, Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2
Open the PDF for Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2 in another window
Includes: Supplementary data
Journal Articles

Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas

Free
Jing Wu, Ying Yuan, Debra A. Long Priel, Danielle Fink, Cody J. Peer, Tristan M. Sissung, Yu-Ting Su, Ying Pang, Guangyang Yu, Madison K. Butler, Tito R. Mendoza, Elizabeth Vera, Salman Ahmad, Christine Bryla, Matthew Lindsley, Ewa Grajkowska, Kelly Mentges, Lisa Boris, Ramya Antony, Nancy Garren, Christine Siegel, Nicole Lollo, Christine Cordova, Orwa Aboud, Brett J. Theeler, Eric M. Burton, Marta Penas-Prado, Heather Leeper, Javier Gonzales, Terri S. Armstrong, Katherine R. Calvo, William D. Figg, Douglas B. Kuhns, John I. Gallin, Mark R. Gilbert
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (12): 3298–3306.
https://doi.org/10.1158/1078-0432.CCR-20-4730
Published: 15 June 2021
View articletitled, Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas
Open the PDF for Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas in another window
Includes: Multimedia, Supplementary data
Journal Articles

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma

Free
Patrick Y. Wen, David A. Reardon, Terri S. Armstrong, Surasak Phuphanich, Robert D. Aiken, Joseph C. Landolfi, William T. Curry, Jay-Jiguang Zhu, Michael Glantz, David M. Peereboom, James M. Markert, Renato LaRocca, Donald M. O'Rourke, Karen Fink, Lyndon Kim, Michael Gruber, Glenn J. Lesser, Edward Pan, Santosh Kesari, Alona Muzikansky, Clemencia Pinilla, Radleigh G. Santos, John S. Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (19): 5799–5807.
https://doi.org/10.1158/1078-0432.CCR-19-0261
Published: 01 October 2019
View articletitled, A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
Open the PDF for A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Genetic Modulation of Neurocognitive Function in Glioma Patients

Free
Yanhong Liu, Renke Zhou, Erik P. Sulman, Michael E. Scheurer, Nicholas Boehling, Georgina N. Armstrong, Spiridon Tsavachidis, Fu-Wen Liang, Carol J. Etzel, Charles A. Conrad, Mark R. Gilbert, Terri S. Armstrong, Melissa L. Bondy, Jeffrey S. Wefel
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (14): 3340–3346.
https://doi.org/10.1158/1078-0432.CCR-15-0168
Published: 14 July 2015
View articletitled, Genetic Modulation of Neurocognitive Function in Glioma Patients
Open the PDF for Genetic Modulation of Neurocognitive Function in Glioma Patients in another window
Includes: Supplementary data
Journal Articles

Facing the Future of Brain Tumor Clinical Research

Free
Mark R. Gilbert, Terri S. Armstrong, Whitney B. Pope, Martin J. van den Bent, Patrick Y. Wen
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (22): 5591–5600.
https://doi.org/10.1158/1078-0432.CCR-14-0835
Published: 13 November 2014
View articletitled, Facing the Future of Brain Tumor Clinical Research
Open the PDF for Facing the Future of Brain Tumor Clinical Research in another window